Lack of very strong association between pre-treatment fibrinogen and PAI-1 with long-term mortality after coronary bypass surgery

Cardiology

Volumn 108, Issue 2, 2007, Pages 82-89

  Sjöland, Helen ^a   Tengborn, Lilian ^b   Stensdotter, Lillemor ^a   Herlitz, Johan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Coronary artery surgery; Fibrinogen; Plasminogen activator inhibitor; Prognosis

Indexed keywords

FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; UNIVERSITY HOSPITAL;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; SWEDEN; TREATMENT OUTCOME;

EID: 34548096986     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095935     Document Type: Article

References (14)

1. Wu KK, Folsom AR, Heiss G, Davis CE, Conlan MG, Barnes R: Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 1992;2:471-480.
2. Aznar J, Estelles A, Tormo G, Sapena P, Tormo V, Blanch S, Espana F: Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Br Heart J 1988;59:535-541.
3. Losner S, Volk BW, Wilensky ND: Fibrinogen concentration in acute myocardial infarction; comparison of the clot density determination of fibrinogen with the erythrocyte sedimentation rate. AMA Arch Intern Med 1954;93:231-245.
4. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG: Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;328:533-537.
5. Tracy RP, Bovill EG, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, Polak JF, Savage PJ: Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1995;15:1269-1279.
6. Paramo JA, Colucci M, Collen D, van de Werf F: Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J (Clin Res Ed) 1985;31:573-574.
7. Stahle E, Bergstrom R, Holmberg L, Edlund B, Nystrom SO, Sjogren I, Hansson HE: Survival after coronary artery bypass grafting. Experience from 4661 patients. Eur Heart J 1994;15:1204-1211.
8. Herlitz J, Brandrup-Wognsen G, Caidahl K, Haglid Evander M, Karlson BW, Hartford M, Karlsson T, Sjöland H: Predictors of death during 10 years after coronary artery bypass grafting with particular emphasis on age. Cor Art Dis 2004;15:163-170.
9. Sergeant P, Blackstone E, Meyns B, Stockman B, Jashari R: First cardiological or cardiosurgical reintervention for ischemic heart disease after primary coronary artery bypass grafting. Eur J Cardiothorac Surg 1998;14:480-487.
10. Hultgren HN, Peduzzi P, Detre K, Takaro T and the study participants: The 5 year effect of bypass surgery on relief of angina and exercise performance. Circulation 1985;72(suppl V):V-79-V-83.
11. Yusuf S, Zucker D, Peduzzi P, Fischer LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R: Effect of coronary artery bypass surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-570.
12. Fibrinogen Studies Collaboration: Plasma fibrinogen level and the risk of major cardiovascular diseases and non-vascular mortality: an individual participant metaanalysis. JAMA 2005;294:1729.
13. Rahel BM, Visseren FL, Suttorp MJ, Plokker TH, Kelder JC, de Jongh BM, Bouter KP, Diepersloot RJ: Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res 2003;60:136-140.
14. Volzke H, Robinson DM, Kleine V, Hertwig S, Schwahn C, Grimm R, Eckel L, Rettig R: Preoperative plasma fibrinogen levels predict mortality after coronary artery bypass grafting. Thromb Haemost 2003;89:885-891.